Skip to main content
Premium Trial:

Request an Annual Quote

Regulus, UCSD Partner on miRNA for Angiogenic Diseases

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Regulus Therapeutics today announced it is collaborating with researchers at the University of California, San Diego School of Medicine to develop treatments for angiogenic disease using microRNA therapeutics.

The collaboration combines Regulus' miRNA platform with UCSD's expertise in animal models of angiogenesis. The collaboration recently received a UC Discovery Grant that promotes work between the university's researchers and industry.

Financial terms of the grant were not disclosed.

David Cheresh, professor of pathology at the UCSD School of Medicine and principal investigator on the grant, said in a statement that research by his colleagues and him suggest miRNA-132 may be a novel angiogenic switch that turns on angiogenesis in quiescent endothelial cells and that it may be a target for decreasing blood vessel formation.

"The object of our collaborative work with Regulus is to advance these initial discoveries and discover additional microRNAs involved in angiogenic diseases," Cheresh said.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.